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Upon infection of their host, temperate phages (viruses that infect bacteria) enter either 1 
a lytic or a lysogenic cycle. The former results in bacterial cell lysis and phage release 2 
(horizontal transmission), while lysogeny is characterized by integration of the phage 3 
in the host genome and dormancy (vertical transmission)1. Co-culture experiments of 4 
bacteria and temperate phage mutants, which are locked in the lytic cycle, have shown 5 
that CRISPR-Cas can efficiently eliminate the invading phages2,3. By contrast, here we 6 
show that when challenged with wild-type temperate phage that can become lysogenic, 7 
type I CRISPR-Cas immune systems are unable to eliminate these phages from the 8 
bacterial population.  In fact, our data suggest that CRISPR-Cas immune systems are 9 
in this context maladaptive to the host due to severe immunopathological effects 10 
brought about by imperfect matching of spacers to integrated phage sequences 11 
(prophages). These fitness costs drive the loss of CRISPR-Cas from bacterial 12 
populations, unless the phage carries anti-CRISPR (acr) genes that suppress the 13 
immune system of the host. Using bioinformatics, we show that this imperfect targeting 14 
is likely to occur frequently in nature. These findings can help to explain the patchy 15 
distribution of CRISPR-Cas immune systems within and between bacterial species and 16 
highlight the strong selective benefits of phage-encoded acr genes for both the phage 17 
and host under these circumstances. 18 
 19 
CRISPR-Cas (Clustered Regularly Interspaced Short Palindromic Repeats; CRISPR-20 
associated) adaptive immune systems provide sequence-specific resistance against phage 21 
infections by inserting phage-derived sequences (spacers) of around 30 bp into CRISPR loci 22 
on the host genome4. Upon reinfection, CRISPR transcripts guide Cas proteins to destroy the 23 
matching target5. The uptake of new spacers is far more efficient if a pre-existing spacer has 24 
partial complementarity to the phage. This process, known as “priming”, is widespread in type 25 
I systems, and provides protection against phage mutants that overcome host resistance by 26 
point mutation of their target sites6,7. However, partially matching spacers can also cause 27 




phage genome is integrated into that of the host and exists in a dormant state until it gets 1 
induced. Lysogeny is common but variable across bacterial genera8. During lysogeny, a 2 
primed CRISPR-Cas immune system may target the partially complementary site in the 3 
prophage, causing damage to both the phage and host DNA and resulting in induction of the 4 
SOS-response9. However, if and how these potentially negative effects impact the 5 
evolutionary and population dynamics of phage-bacteria interactions remains unclear, since 6 
these processes have only been studied in the context of virulent phages2,3. 7 
 8 
Temperate phages persist despite CRISPR  9 
To explore this, we infected Pseudomonas aeruginosa PA14 with either the temperate phage 10 
DMS3 or the virulent mutant DMS3vir (a DMS3 mutant that is locked in the lytic cycle through 11 
mutation of the c-repressor gene) and monitored bacterial and phage population dynamics for 12 
8 days. P. aeruginosa strain PA14 carries a type I-F CRISPR-Cas immune system, with spacer 13 
1 of CRISPR array 2 having an imperfect match (5 mismatches) to gene 42 of DMS39,10. As 14 
previously reported3, DMS3vir was driven extinct by WT bacteria at 5 days post-infection (dpi) 15 
due to the evolution of CRISPR-based resistance, whereas a ∆cas7 mutant - lacking a 16 
functional CRISPR-Cas system - evolved surface-based resistance that allowed for phage 17 
persistence (Fig. 1a-c). In contrast, both WT and ∆cas7 bacteria were unable to clear wildtype 18 
DMS3 infections (Fig. 1b), suggesting that the ability to transmit vertically (i.e. lysogeny) is a 19 
critical determinant of temperate phage survival when bacteria encode CRISPR-Cas immune 20 
systems. To understand the evolutionary drivers of these population dynamics, we isolated 21 
bacterial clones from the DMS3-infected cultures at 3 dpi and quantified the proportion of 22 
lysogens and bacteria with CRISPR-based and surface-based resistance. This showed that 23 
CRISPR resistance evolution was significantly reduced in WT populations exposed to DMS3 24 
compared to DMS3vir (Fig. 1c,d), and instead many WT bacteria carried the DMS3 prophage 25 
(Fig. 1d), which confers phage resistance through superinfection exclusion. However, 26 
lysogeny levels were reduced in WT hosts compared to the ∆cas7 strain, which almost 27 




The difference in DMS3 and DMS3vir persistence could be due to either differences in 1 
host resistance evolution or the ability of DMS3 to transmit vertically while continuously 2 
releasing free phage particles through prophage induction. To distinguish between these 3 
possibilities, we infected WT and ∆cas7 strains with an equal mix of DMS3 and DMS3vir and 4 
observed similar bacterial and phage population dynamics and resistance evolution to those 5 
during infection with temperate phage alone (Extended Data Fig. 1). Next, we examined how 6 
the relative frequencies of DMS3 and DMS3vir changed over time (Fig. 2a,b). Initially, 7 
DMS3vir outcompetes DMS3, consistent with the idea that high densities of sensitive hosts 8 
favour horizontal transmission (i.e. the lytic replication cycle)11. However, at later time points, 9 
all free phage particles belong to the DMS3 genotype. As the host population experienced by 10 
the two phage genotypes was identical, this demonstrates that vertical transmission facilitates 11 
the observed persistence of DMS3. Interestingly, persistence of free phages was facilitated 12 
despite low frequencies of lysogeny in WT compared to ∆cas7 bacteria (Fig. 2a,b, compare 13 
blue and red lines, and Extended Data Fig. 1c,d).  14 
Next, to understand why lysogen formation was depressed in WT compared to ∆cas7 15 
bacteria, we performed temporal sampling of DMS3-infected populations over 7 days. 16 
Interestingly, this revealed that lysogeny in WT bacteria was already depressed at 1 dpi and 17 
continued to decline until 7 dpi, whereas the proportion of lysogens in isogenic mutants with 18 
a defective CRISPR-interference pathway (∆cas3 and ∆cas7 mutants) was high and constant 19 
during this same period (Fig. 2c). Crucially, the proportion of DMS3 lysogens at 1 dpi was also 20 
depressed in a ∆cas1 mutant, which is unable to acquire novel spacers (adaptation) but is 21 
proficient in detecting and destroying complementary DNA (interference). However, in this 22 
background, the proportion of lysogens increased between 1 and 7 dpi to levels similar to the 23 
CRISPR-interference mutants (Fig. 2c). These data therefore suggest that WT and ∆cas1 24 
bacteria are partially resistant to DMS3 infection, even in the absence of spacer acquisition, 25 
resulting initially in fewer lysogens and further reductions if the hosts carry the genetic 26 





Mismatched spacers are maladaptive 1 
We hypothesized that the observed suppression of lysogeny in WT and ∆cas1 backgrounds 2 
was dependent on the imperfect match (5 mismatches) between gene 42 of DMS3 and spacer 3 
1 of CRISPR array 29,10. To test this, we infected a strain lacking CRISPR array 2 (∆CRISPR2) 4 
with DMS3 and observed that plasmid-based expression of spacer 1 (∆CRISPR2-sp1) led to 5 
similar population dynamics to those observed during infection of the wildtype strain (Extended 6 
Data Fig. 2a,b) and suppression of lysogeny (Extended Data Fig. 2c), while expression of a 7 
control non-targeting spacer (∆CRISPR2-NT) did not. To further corroborate the hypothesis 8 
that the suppression of lysogeny was caused by partial CRISPR-Cas resistance, we 9 
performed infections with phages carrying anti-CRISPR genes (acr), which are widespread 10 
and diverse genes (currently classified into 45 families) carried by a range of different mobile 11 
genetic elements, that block CRISPR-interference12. As expected, infection of WT bacteria 12 
with a mutant phage DMS3 carrying either acrIF1 or acrIF4, both of which block the I-F 13 
CRISPR-Cas system of PA1413, showed similar lysogeny levels to those observed for 14 
interference-deficient mutants (Extended Data Fig. 3a).  15 
Intriguingly, although lysogen formation was reduced in WT and ∆cas1 bacteria, the 16 
concentration of free phages was actually higher during the early stages of DMS3 infection of 17 
these hosts (Fig. 2d). This effect disappeared by 7 dpi - if bacteria were unable to acquire new 18 
spacers (∆cas1) - or inverted at 4 dpi if they had a functional CRISPR-Cas system (Fig. 2d). 19 
This also coincided with reduced bacterial densities of WT and ∆cas1 populations compared 20 
to CRISPR-interference mutants during the early stages of the phage epidemic (Fig. 2e), 21 
suggesting that functional CRISPR-Cas immune systems may be maladaptive in this context. 22 
We speculated that the high DMS3 titres during early stages of infection of WT and ∆cas1 23 
bacteria (Fig. 2d and 1b) and the concurrent reduced bacterial densities could be due to 24 
interactions between the CRISPR interference machinery and the partially complementary 25 
prophage (i.e. autoimmunity), which can activate an SOS-response9 and which in turn may 26 
trigger prophage induction14. To test this, we isolated 6 independent DMS3 lysogens from WT, 27 




costs of lysogeny in WT and ∆cas1 backgrounds, whereas growth of ∆cas7 lysogens was 1 
unaffected (Fig. 3a-c). Growth of lysogens lacking spacers 1 and 2 of CRISPR 2 (∆sp1-2) or 2 
lacking the entire CRISPR 2 array (∆CRISPR2-NT) was comparable to that of ∆cas7 lysogens 3 
(Fig. 3d and Extended Data Fig. 2c), but restoring the expression of CRISPR 2 spacer 1 4 
(∆CRISPR2-sp1) resulted in a reduced growth rate (Extended Data Fig. 2d), confirming that 5 
this spacer is responsible for the reduced fitness of WT bacteria carrying the prophage. 6 
Competition of lysogens against bacteria with surface-based resistance confirmed a fitness 7 
cost of lysogeny in the WT, but not in the ∆cas7 background (Fig. 3e,f, relative fitness<1, one-8 
tailed Wilcoxon and t-tests, WT: df=5, p=0.016; ∆cas7: t5=3.6551, p=0.99). This effect was 9 
reduced if the prophage possessed an acr gene (Fig. 3e, one-tailed t-test, acrIF1: t5=16.562, 10 
acrIF4: t5=14.805 and p<0.0001 in both cases), whereas acr genes had no effect on fitness of 11 
∆cas7 lysogens (Fig. 3f, ANOVA F2,15 =0.205, p=0.82). 12 
Next, we estimated prophage induction levels in WT and ∆cas7 lysogens. To this end, 13 
we pelleted bacterial cultures and washed away free phages, followed by resuspension in 14 
fresh medium, and monitored bacterial densities and free phage accumulation over 25 hours. 15 
While initial cell densities were similar for all strains, growth of WT cultures plateaued at a 16 
lower density (Extended Data Fig. 3b), yet they accumulated more phage particles compared 17 
to ∆cas7 lysogens (Extended Data Fig. 3c), unless the prophage carried an acr gene. Taken 18 
together, these data support the hypothesis that, unless DMS3 encodes acr genes, CRISPR-19 
Cas causes immunopathology during vertical transmission of the phage, which triggers 20 
prophage induction and hence explains the high free phage titres during the early infection 21 
stage. 22 
 These immunopathological effects may select for CRISPR mechanisms that 23 
selectively target phages during their lytic cycle, as has been described for type III 24 
systems15,16. However, competition between DMS3 and DMS3vir phages showed that the 25 
main determinant of their relative fitness is the proportion of sensitive bacteria in the 26 
population11 (Extended Data Fig. 3d, two-way ANOVA F6,83=3.1683, p=0.008) and is 27 




surface-based (Extended Data Fig. 3d, F1,76=2.8923, p=0.09). This suggests that the type I 1 
CRISPR-Cas system of P. aeruginosa lacks the ability to distinguish between phages that 2 
enter lytic or lysogenic cycles. 3 
Given these opposing fitness effects of CRISPR-Cas immune systems during 4 
horizontal2,3, and vertical transmission of DMS3 (Fig. 3), it is unclear what the net fitness 5 
effects of CRISPR-Cas systems are during temperate phage infections. To explore this, we 6 
competed WT and ∆cas7 strains in the presence of either DMS3vir, DMS3, DMS3-acrIF1 or 7 
DMS3-acrIF4 phages and determined their relative fitness at day 1, 3 and 7. Strikingly, while 8 
WT bacteria were fitter than ∆cas7 in the presence of virulent phage (Fig. 4a, one-tailed 9 
Wilcoxon test, relative fitness>1; p=0.016), they were considerably less fit during temperate 10 
phage infection (Fig. 4a, relative fitness<1; p=0.018), unless the temperate phage carried acr 11 
genes (Fig. 4a, relative fitness ≠1; p=0.16). Hence, in this context acr genes not only provide 12 
a benefit to the phage during both horizontal3,17,18 and vertical transmission (Fig. 4b, one-tailed 13 
t-test: relative fitness ≠1, acrIF1; t5=39.30, p<0.0001; acrIF4; t5=11.61, p <0.0001), but also to 14 
the host by preventing autoimmunity.  15 
 16 
Bacteria evolve to lose CRISPR-Cas 17 
We next monitored whether WT lysogens evolved to alleviate these autoimmunity costs 18 
through mutation of their immune system or the prophage. Lysogens in WT and adaptation-19 
deficient ∆cas1 backgrounds, which had reduced growth during early infection, were selected 20 
from the late infection stage (7 dpi). Growth curves revealed that the negative fitness 21 
consequences of CRISPR-Cas immune systems had disappeared in these “late lysogens”, 22 
and they now had growth rates comparable to ancestral hosts lacking the prophage (Fig. 4c,d, 23 
compare to Fig. 3a,b). A competition experiment confirmed this finding, showing that late 24 
lysogens in a WT background were fitter than a surface mutant (Fig. 4e, one-tailed t-test, 25 
relative fitness>1; t5=5.985, p<0.001), and the presence of acr genes in the prophage no 26 
longer increased the fitness of the host (Fig. 4e, one-tailed t-test: acrIF1; t5=-5.5085, p=1.00; 27 




To understand the mechanistic basis for this alleviation in fitness costs, we performed 1 
PCR analyses of the CRISPR loci of 6 independent lysogens in WT, ∆cas1 and ∆cas7 2 
backgrounds, isolated from early or late time points after infection. Both CRISPR loci (1 and 3 
2) amplified as expected in early lysogens (Extended Data Fig. 4a), however, amplification 4 
failed in many late lysogens in WT and ∆cas1 backgrounds (Extended Data Fig. 4a, negative 5 
PCR indicated by red frame), suggesting that the CRISPR-Cas locus was lost in these clones. 6 
Whole genome sequencing of late lysogens revealed large genomic deletions  associated with 7 
prophage integration (between ~ 50 and 230 kb) that encompassed the entire CRISPR-Cas 8 
locus - but contained no essential gene19 - in WT and ∆cas1 backgrounds, while the genome 9 
remained intact in ∆cas7 late lysogens (Extended Data Fig. 4c-e and Extended Data Table 1). 10 
This loss of the CRISPR-Cas locus was clearly driven by the immunopathological effects of 11 
CRISPR 2 spacer 1, as the locus was maintained in lysogens lacking CRISPR 2 (∆CRISPR2) 12 
but lost when expression of spacer 1 was restored (∆CRISPR2-sp1) (Extended Data Fig. 2b). 13 
The loss of CRISPR-Cas was also avoided when WT bacteria were lysogenized by DMS3 14 
carrying acr genes (Extended Data Fig. 4a).   15 
 16 
Generality of the empirical data  17 
Collectively, these data show that temperate phage infection can drive rapid loss of CRISPR-18 
Cas immune systems from bacterial genomes due to immunopathological effects that manifest 19 
during vertical transmission. To generalize our findings beyond phage DMS3 (belonging to 20 
Caudovirales), we introduced a priming spacer with one mismatch against the Pf5 prophage 21 
(Inoviridae) that is naturally present in the genome of WT PA1420. Expression of a Pf5-priming 22 
spacer caused reduced growth of the WT strain and strong selection for bacteria carrying a 23 
deletion in their CRISPR-Cas immune system (Extended Data Fig. 5). These observations 24 
therefore suggest that immunopathological effects generally drive selection for CRISPR loss, 25 
whenever hosts carry spacers primed against their prophage. Indeed, when we formalized 26 




dynamics as those observed in our experiments (Extended Data Fig. 6; See Supplemental 1 
Information for a detailed description of the model). 2 
Crucially, priming is thought to be frequent in nature due to the relaxed sequence 3 
identity requirements for triggering this pathway, with up to 13 mismatches between a pre-4 
existing spacer and the target being tolerated7. Indeed, analysis of the spacers from >170k 5 
bacterial genomes and a dataset of ~20k prophages21 revealed that pre-existing spacers with 6 
perfect or imperfect (1-5 mismatches) targets to temperate phages are common within genera 7 
(Extended Data Fig. 7; see also Supplemental Information for further information). On 8 
average, 49% of all prophages were targeted by priming spacers carried by bacteria within 9 
the same genera as the lysogen (Extended Data Fig. 7c). If mismatched spacers generally 10 
cause residual DNA cleavage activity by the CRISPR immune system, they would be expected 11 
to cause similar immunopathological effects as those observed for the P. aeruginosa-DMS3 12 
interaction. Indeed, when all complete P. aeruginosa genomes were assessed, we observed 13 
a significant enrichment for an increase in acr frequency when self-targeting spacers matched 14 
prophages (Extended Data Fig. 8), which is consistent with the idea that these spacers cause 15 
immunopathological effects. Together, these bioinformatic analyses suggest that maladaptive 16 
effects of CRISPR-Cas against temperate phages are likely common in nature. 17 
In natural ecosystems, bacteria are frequently exposed to both temperate and virulent 18 
phages, and the latter may superinfect the lysogens. To further generalize our findings, we 19 
explored whether these superinfections would likely change the observed population and 20 
evolutionary dynamics. We found that mixed infection of WT PA14 with temperate phage 21 
DMS3 and virulent phage LMA2 (which can superinfect DMS3 lysogens) resulted in similar 22 
rates of lysogenization (Extended Data Fig. 9d,e) and high fitness costs of CRISPR-Cas 23 
(Extended Data Fig. 9g), that drive evolutionary loss of the immune system (Extended Data 24 
Fig. 9f). Our theoretical model recovered similar dynamics, independent of whether CRISPR-25 
based resistance evolves against only one (as in our experiment) or against both phages 26 






The observation that approximately 60% of all bacterial genotypes lack CRISPR-Cas systems 2 
and that closely related strains differ in whether they encode cas genes suggests that these 3 
systems are frequently gained and lost from bacterial genomes22. While phage infection is 4 
typically assumed to be an important selective force for the maintenance of CRISPR-Cas 5 
immune systems, this work reveals their rapid loss when exposed to a temperate phage, as a 6 
result of immunopathological effects when the CRISPR immune system is “primed” against 7 
this phage. Certain CRISPR-Cas immune systems may mitigate some of these autoimmunity 8 
costs by limiting the spacer acquisition and cleavage of transcriptionally silent elements15,23. 9 
However, CRISPR-based autoimmunity is frequently reported24–27, and the high frequencies 10 
at which primed self-targeting interactions occur suggests this is likely a major driver of the 11 
evolutionary loss of CRISPR systems in nature. 12 
 13 
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Main Figures  1 
 2 
Figure 1 | Phage persistence and host resistance evolution upon virulent or temperate phage 3 
infections. (a) Phage densities over time following infection of WT PA14 or the ∆cas7 mutant with 4 
DMS3vir or (b) DMS3. The limit of phage detection is 200 PFU/ml. (c) Fraction of bacteria that had 5 
evolved resistance at 3 dpi following infection with phage DMS3vir or (d) DMS3, either through CRISPR-6 
Cas (CRISPR), surface modification (sm) or lysogeny (Lysogen). Fractions are based on 24 random 7 
clones per replicate experiment. In all panels, data shown are the mean of 6 biologically independent 8 
replicates per treatment. Error bars represent 95 % confidence intervals (c.i.). 9 
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Figure 2 | The impact of CRISPR adaptation and interference on lysogeny and phage 3 
persistence. (a) Relative frequency of DMS3 over time following infection of WT PA14 or (b) the ∆cas7 4 
mutant host with an equal mix of DMS3 and DMS3vir. Relative frequencies are shown both for the free 5 
and total (i.e. including lysogens) phage population. (c) Percentage of DMS3 lysogens in the host 6 
population at 1, 3, or 7 dpi of either the WT PA14 strain, the isogenic CRISPR-interference deficient 7 
mutants ∆cas7 and ∆cas3, or the isogenic CRISPR-adaptation deficient mutant ∆cas1, based on 24 8 
random clones per replicate experiment per time point. (d) DMS3 phage and (e) bacterial densities 9 
during this co-culture experiment. In all panels, data shown are the mean of 6 biologically independent 10 
replicates per treatment. Error bars represent 95 % c.i.  11 
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Figure 3 | Fitness of lysogens with an active CRISPR-Cas system is reduced unless they encode 2 
acr genes. (a) 24-hour growth curves of uninfected control cultures, or 6 independent DMS3 lysogens 3 
in WT PA14, (b) ∆cas1 (CRISPR-adaptation deficient), and (c) ∆cas7 (CRISPR-interference deficient) 4 
genetic backgrounds. Lysogens were isolated from day 1 of the co-culture experiment shown in Fig. 2. 5 
Curves are the mean of 6 (a,b) or 4 (c) replicates and shaded areas represent standard error of the 6 
mean. (d) 24-hour mean growth curves of 6 lysogens in WT, ∆cas7 and ∆sp1-2 (carrying a deletion of 7 
CRISPR2 spacers 1 and 2) backgrounds isolated from 6 biological replicates. Each growth curve was 8 
performed in 5 technical replicates. Shaded areas represent standard error of the mean. (e) Fitness 9 
relative to a surface mutant (sm) of WT PA14 lysogens isolated 1 day post infection with DMS3 or (f) 10 
PA14 ∆cas7 lysogens isolated 1 day post infection with DMS3. Relative fitness was determined after 1 11 
day of competition. Each point represents the average relative fitness of one independent lysogen clone 12 
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Figure 4 | Lysogens evolve to mitigate fitness costs. (a) Relative fitness of WT during competition 2 
with ∆cas7 hosts following infection with 104 PFU of either DMS3, the lytic mutant DMS3vir, or the anti-3 
CRISPR-encoding mutants DMS3-acrIF1 and DMS3-acrIF4. (b) Relative fitness of DMS3 (free phages 4 
+ lysogens) following 3 days of competition with DMS3-acrIF1 or DMS3-acrIF4 on either WT PA14 or 5 
∆cas7 mutant. (c) 24-hour growth curves of uninfected control cultures, or 6 biologically independent 6 
DMS3 lysogens in the WT PA14 or (d) ∆cas1 genetic backgrounds, which were isolated from day 7 of 7 
the co-culture experiment shown in Fig. 2. Curves are the mean of 6 replicates and error bars represent 8 
standard error of the mean. (e) Relative fitness of a DMS3 lysogen in a WT PA14 genetic background, 9 
isolated from day 5 of a co-culture experiment, during competition with a surface mutant. Relative fitness 10 
was calculated after 1 day of competition. All panels show the mean of 6 biologically independent 11 
replicates per treatment. Error bars represent 95 % c.i. (panels a,b and e)  or standard error of the mean 12 
(panels c and d). 13 












































































WT lysogen x sm1




























Bacterial strains and viruses 2 
P. aeruginosa UCBPP-PA14 (referred to as WT) and P. aeruginosa UCBPP-PA14 csy3::lacZ 3 
(referred to as ∆cas7) were used in all experiments (described previously28). The surface 4 
mutant Tn::pilA lacking a pilus (referred to as sm2) has been described previously29 and was 5 
used in competition experiments with bacteriophage insensitive mutant (BIM) with 2 additional 6 
acquired spacers over those present in the WT strain (as described previously2). 7 
Lysogens in WT or cas mutant backgrounds used in growth curves, fitness and induction 8 
experiments were generated in this study and the presence of a prophage was confirmed by 9 
PCR. PA14 strains ∆cas3, ∆cas1, ∆CRISPR2 and CRISPR2 ∆spacer1-2, respectively 10 
identified as SMC4268, SMC4277 and SMC3895 and SMC4707, were described 11 
elsewhere10,28. 12 
Phage amplifications were carried out on P. aeruginosa UCBPP-PA14 csy3::lacZ. DMS3 and 13 
the obligately lytic variant DMS3vir have been described previously30. DMS3-acrIF1 and 14 
DMS3-acrIF4 phages were generated in this study following the method for hybrid phage 15 
construction detailed in an earlier study17. DMS3vir-acrIF1 was used in downstream analyses 16 
and has been described elsewhere3. A virulent phage capable of infecting DMS3 lysogens 17 
(LMA2, described previously31) was used in co-culture experiments.  18 
All bacterial strains were grown at 37°C in LB broth or M9 medium (22 mM Na2HPO4; 22 mM 19 
KH2PO4; 8.6 mM NaCl; 20 mM NH4Cl; 1 mM MgSO4; 0.1 mM CaCl2) supplemented with 0.2% 20 
glucose. When appropriate, medium was further supplemented with gentamycin (50 mg/ml) 21 
and arabinose (1% w/v).  22 
 23 
Evolution experiments 24 
To monitor the evolution of bacterial resistance in response to phage infection and the 25 
associated bacterial and phage population dynamics, microcosms with 6 ml of M9 medium 26 
supplemented with 0.2% glucose were inoculated with approximately 106 colony forming units 27 




cultures were infected with 104 plaque forming units (PFU) of DMS3vir, DMS3, DMS3-acrIF 1 
or LMA2 phages, followed by incubation at 37ºC and shaking at 180 revolutions per minute 2 
(rpm). Cultures were transferred 1:100 into fresh medium every 24 hours for 5-8 days. All 3 
experiments were performed in 6 independent replicates. 4 
Determination of resistance phenotypes 5 
Resistance phenotypes were determined at day 3 or day 7 by streaking individual colonies 6 
(24 randomly picked per replicate) through DMS3vir and phage DMS3vir-acrIF1. Surface 7 
modification was confirmed by colony morphology, broad-range resistance to DMS3vir and 8 
DMS3vir-acrIF1, and a lack of newly acquired spacers. Lysogens were determined by broad 9 
resistance to both phage and a positive PCR amplification of the c-repressor gene in bacterial 10 
genome, amplified using primers 5’-GCGGAATGAGCGCTAAACC-3’ and 5’-11 
CAAGTGCTTTAGCGAGGAATGC-3’. CRISPR-resistance was confirmed by resistance to 12 
DMS3vir, but not to DMS3vir-acrIF1 and a PCR confirming spacers had been added to one of 13 
the CRISPR arrays. Primers 5’-CTAAGCCTTGTACGAAGTCTC-3’ and 5’-14 
CGCCGAAGGCCAGCGCGCCGGTG-3’ were used to amplify CRISPR array 1, and primers 15 
5’-GCCGTCCAGAAGTCACCACCCG-3’ and 5’-TCAGCAAGTTACGAGACCTCG-3’ for 16 
CRISPR array 2. As a positive control for PCR, primers 5’-GCTTGCAGTTCCTCAACGAG-3’ 17 
and 5’-CACCAGGAAATTCAGGTAGGG-3’ were used to amplify the housekeeping control 18 
gene fimV involved in pilus formation.  19 
Bacterial and phage titres 20 
Bacterial densities were determined by plating on LB agar dilutions of samples taken at each 21 
transfer in M9 salts (22 mM Na2HPO4; 22 mM KH2PO4; 8.6 mM NaCl; 20 mM NH4Cl; 1 mM 22 
MgSO4; 0.1 mM CaCl2). Phages were extracted at each transfer by chloroform extraction 23 
(sample: chloroform 10:1 v/v), and phage titers were determined by spotting serial dilutions of 24 
isolated phage samples in M9 salts on a lawn of PA14∆cas7. 25 
 26 
Phage Competition 27 




Competition experiments were performed in glass vials in 6 ml of M9 medium. Experiments 1 
were initiated by inoculating a 1:100 dilution of different mixes of overnight cultures of the 2 
∆cas7 strain and either the surface mutant ∆pilA29 (sm2) or BIM strain (2 spacers targeting 3 
DMS3). A 50:50 mix of phages DMS3vir and DMS3 was added (108 PFU) and the vials were 4 
incubated at 37˚C with shaking for 8 hours. Phages were extracted by chloroform extraction 5 
and spot assays carried out to determine phage titres. To determine phage relative 6 
frequencies, plaque assays were carried out by serially diluting phage extractions and adding 7 
200 µl of the selected dilution to 600 µl of ∆cas7 overnight culture and 6 ml molten top agar 8 
(0.5 %), which was then poured over a prewarmed LB agar plate. The plates were incubated 9 
overnight at 37˚C and the plaques generated by temperate and virulent phages were 10 
discriminated by differences in opacity, and a subset confirmed by PCR. All experiments were 11 
performed in 6 replicates. 12 
Coevolution competitions 13 
Phage competition was also measured in the presence of host evolution. Initially sensitive 14 
∆cas7 or WT hosts were infected with 104 PFU of a 50:50 mix of temperate and virulent phages 15 
(DMS3 and DMS3vir). The experiment was run as a standard evolution experiment, and 16 
bacterial and phage titres measured every day for 7 days. Resistance phenotypes were 17 
assessed on days 3 and 7, as described above, and plaque assays used to determine the 18 
ratio of temperate to virulent phage at each time point. 19 
Competition DMS3 x DMS3-acrIF 20 
Temperate DMS3 was also competed against a mutant encoding Acr proteins. Initially 21 
sensitive ∆cas7 or WT hosts were infected with 104 PFU of a 50:50 mix of DMS3 and DMS3-22 
acrIF1 (or DMS3-acrIF4). The experiment was run for 3 days and samples of total phage 23 
population (i.e. free phages + prophages, no chloroform extraction) were collected and 24 
immediately frozen every day. Phage titres were measured every day by spot test. To 25 
determine their relative fitness, the relative frequencies of each phage were determined at 26 





Expression of priming spacers  1 
The expression of the CRISPR RNA (crRNA) encoding spacer 1 of CRISPR2 was restored in 2 
strain PA14∆CRISPR2 using an arabinose inducible expression vector (pHERD30T-based). 3 
Briefly, oligonucleotides containing the sequences of a non-targeting (NT) spacer (5’-4 
GTCTTCTTTGAGCTTCCAGAGAACTGAAGAC-3’) or of spacer 1 (5’-5 
ATCAGCCGGACGTTGTAGTAGTCGAGCGCGGT-3’) and flanked by two CRISPR2 repeats 6 
were annealed and ligated between NcoI/HindIII restriction sites. The resulting plasmids were 7 
transformed into PA14∆CRISPR2 to generate the strains ∆CRISPR2-sp1 and ∆CRISPR2-NT, 8 
respectively. Similarly, a spacer targeting the natural Pf5 prophage of PA14 (accession 9 
number AY324828) with 1 mismatch 5’-AGTCCTTCTAGTGAGCGGAACCAAAATCTATT-3’ 10 
was expressed in WT PA14 strain.  11 
 12 
Measuring prophage induction 13 
Single colonies were picked from plated lysogens and grown in LB media overnight at 37˚C 14 
with 180 rpm shaking. The overnight culture was diluted 1:100 in fresh M9 media and grown 15 
until optical density (OD600nm) reached ~0.1. The cultures were then pelleted by centrifugation 16 
and the pellet washed 5 times in M9 buffer, then resuspended in 10 ml of M9 media. The 17 
cultures were grown at 37˚C with shaking and samples taken regularly for phage quantification 18 
by spot assay and OD600nm measurements using a Biotek synergy 2 plate reader.  19 
 20 
24-hour growth curves 21 
Single colonies were isolated and grown in M9 media overnight at 37 ̊ C with 180 rpm shaking. 22 
The following day, this culture was diluted 1:100 and 250 µl of this mixture was added to a 96-23 
well plate and growth curves were measured for 23 hours in a Thermo Scientific Varioskan 24 
flash plate reader with continuous shaking at 180 rpm. Readings of OD600nm were taken every 25 
15 minutes and the plate kept at 37˚C. All growth curves were performed in 6-12 replicates. 26 
 27 




Competition experiments were performed in 6 ml M9 medium supplemented with 0.2% 1 
glucose. Competition experiments were initiated by inoculating 1:100 from a 1:1 mixture of 2 
overnight cultures (grown in M9 medium + 0.2% glucose) of each strain. If phages were 3 
included, they were added at a concentration of 104 PFU. Cells were transferred 1:100 daily 4 
into fresh broth. At varying time points, from 1 to 7 days, samples were taken and cells were 5 
serially diluted in M9 salts and plated on LB agar supplemented with 50 μgml-1 X-gal (to allow 6 
discrimination between strains carrying the lacZ gene (blue) or those without (white)). All 7 
experiments were performed in 6 replicates. Relative fitness was calculated from changes in 8 
the relative frequencies of blue and white colonies (rel. fitness = [(fraction strain A at t=x) * (1 9 
– (fraction stain A at t=0))] / [(fraction strain A at t=0) * (1 – (fraction strain A at t=x)]). 10 
 11 
Whole-genome sequencing and bioinformatic analyses 12 
Lysogen clones in WT, ∆cas7 and ∆cas1 backgrounds were isolated from the late timepoints 13 
of the evolution experiments. Standard genome sequencing and standard bioinformatic 14 
analyses were provided by MicrobesNG (as described in http://www.microbesng.uk). Raw 15 
read sequencing data have been deposited in the European Nucleotide Archive under the 16 
study accession number PRJEB34503. Trimmed reads were mapped to WT PA14 reference 17 
genome (accession number NC_008463) with Geneious® 9.1.8 software using Bowtie2 18 
mapper33 to identify the genomic deletion. Reads were also mapped to DMS3 reference 19 
genome (accession number DQ631426) and hybrid reads composed of a 5’-extremity 20 
matching PA14 and a 3’-extremity matching the 5’-end of DMS3 (and vice versa, i.e. reads 21 
composed of a 5’-extremity matching the 3’-end of DMS3 and a 3’-extremity matching PA14) 22 
were extracted. These hybrid reads were then mapped back to PA14 genome to identify 23 
prophage insertion sites. 24 
 25 
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Extended Data Figure Legends 1 
Extended Data Figure 1 | Infections with a 50:50 mix of temperate:virulent phages. (a) Bacterial 2 
and (b) phage titres during a co-culture experiment of either WT PA14 (red) or ∆cas7 mutant (blue) and 3 
a 50:50 mix of DMS3 and DMS3vir. (c) Resistance phenotypes at day 3 or (d) day 7 of the co-culture 4 
experiment, based on 24 random clones per replicate experiment. Data shown are the mean of 6 5 
biological replicates per treatment. Error bars represent 95 % c.i. 6 
 7 
Extended Data Figure 2 | Suppression of lysogeny and immunopathological effects are due to 8 
spacer 1 of CRISPR array 2. (a) Phage and (b) bacterial titres during co-culture of phage DMS3 and 9 
P. aeruginosa PA14∆CRISPR2 expressing either a non-targeting spacer from a plasmid (∆CRISPR2-10 
NT) or the original CRISPR2 spacer 1 (∆CRISPR2-sp1). (c) The proportion of lysogens and (d) the 11 
frequency of loss of CRISPR-Cas immune systems at 1 and 3 dpi, based on PCR analyses of 24 12 
random clones per replicate experiment. Panels a to d show the mean of 3 biological replicates (error 13 
bars represent 95 % c.i.) (e-g) Growth of 3 independent lysogen clones isolated at 3 dpi as determined 14 
by OD600nm measurements. (e) ∆CRISPR2-NT and (f) ∆CRISPR2-sp1 lysogen clones carry the 15 
ancestral ∆CRISPR2 CRISPR-Cas immune system, while (g) ∆CRISPR2-sp1 lysogen clones have 16 
evolved to lose CRISPR-Cas.  17 
 18 
 Extended Data Figure 3 | Prophage induction rates are increased in hosts with active CRISPR-19 
Cas. (a) Percentage lysogens formed upon infection of WT host with DMS3 phages engineered to 20 
produce AcrIF1 or AcrIF4 anti-CRISPR proteins. (b) Optical density and (c) phage titres during growth 21 
of lysogens of DMS3, DMS3-acrIFI or DMS3-acrIF4 in a WT PA14 or ∆cas7 genetic background. (d) 22 
Relative fitness of DMS3 phage during competition with the virulent mutant DMS3vir in the presence of 23 
varying fractions of sensitive (∆cas7) host and resistant hosts with either CRISPR- (BIM) or surface-24 
based immunity (sm2) against these phages. Data show mean fitness at 8 hours post-infection. All 25 
panels show the mean of 6 biological replicates and error bars represent 95 % c.i. 26 
 27 
Extended Data Figure 4 | Lysogens lose their CRISPR-Cas immune systems. (a) PCR amplification 28 
of the c-repressor gene of the prophage (c-rep, 611 bp), the fimV gene (located ~ 1 Mb from the CRISPR 29 
loci, positive control for the PCR, 116 bp) and CRISPR loci 1 (349 bp) and 2 (206 bp) on the host 30 




backgrounds isolated at 1 or 7 dpi as well as on 6 independent lysogens of DMS3, DMS3-acrIF1 or 1 
DMS3-acrIF4 (WT background) isolated at 6 or 120 hours post infection. Red frames indicate failure to 2 
amplify a product. PCR amplifications were performed on clones isolated from 3 biological replicate 3 
experiments and produced similar results. For gel source data, see Supplementary Figure 1. (b) 4 
Schematic of the CRISPR-Cas locus of PA14 WT which spans a region of around 11 kb. Primers used 5 
to amplify regions of CRISPR arrays 1 or 2 are shown as red arrows. (c) Whole genome sequencing of 6 
DMS3 lysogens that lost their CRISPR-Cas system (red frames in panel a) in WT PA14, (d) ∆cas1 or 7 
(e) ∆cas7 backgrounds. Graphs show the read coverage of the region encompassing positions 8 
2,700,000 – 2, 970,000 of WT PA14 genome. CRISPR-Cas locus is indicated by a green box on the x-9 
axis. A genome map depicting coding sequences (yellow arrows) is shown above the graphs. Region 10 
comprised between 2.84-2.88 Mb includes sequences that are repeated elsewhere on PA14 genome, 11 
explaining why reads mapping these positions are still detected in some of the deletion mutants. High 12 
peak at the 3’-end of the CRISPR locus corresponds to the coverage of spacer 20 of CRISPR2 by reads 13 
that derive from DMS3 prophage (5’- and 3’ extremities of these reads map to phage genome). Spacer 14 
20 of CRISPR2 has 100% identity to DMS3 but is not immunogenic because there is no consensus 15 
PAM.  16 
 17 
Extended Data Figure 5 | Expression of Pf5 priming spacer in P. aeruginosa PA14. (a) Growth of 18 
∆cas7 (dashed line) or WT (solid line) clones carrying an expression plasmid encoding a non-targeting 19 
spacer (pNT) or a spacer targeting PA14 natural prophage Pf5 with one mismatch (pPf5-MS) as 20 
determined by OD600nm measurements. Graphs show mean curves from 6 biological replicates and 21 
shaded areas corresponds to 95% c.i. (b) Relative fitness of WT pNT or WT pPf5-MS during competition 22 
with ∆cas7 pNT. Data shown are the mean of 6 biological replicates per treatment. Error bars represent 23 
95 % c.i.  24 
 25 
Extended Data Figure 6 | Simulations of population and evolutionary dynamics of bacteria-26 
phage interactions, when virulent and temperate phages compete on bacteria with CRISPR-Cas 27 
system. Graphs show densities of (a) susceptible hosts, CRISPR-resistant bacteria and lysogens or 28 
(b) free viruses over time, as well as (c) the frequency of temperate phages in a population composed 29 




vertically, whereas virulent phages can transmit only horizontally and cannot superinfect lysogens. (d) 1 
Frequency of evolutionary loss of CRISPR-Cas system in the lysogen population over time. The 2 
simulations shown in (a-d) reflect the situation where both virulent and temperate phages lack acr 3 
genes, whereas (e-h) reflect the scenario where the temperate type carries an acr.  4 
 5 
Extended Data Figure 7 | Matches between spacers and temperate phages are widespread. (a) 6 
Total matches between non-redundant spacers (n=1,239,973) from 171,361 RefSeq and Genbank 7 
complete genomes and a non-redundant set of temperate phages (n=19,996)21. The counts of perfect 8 
(0) or mis-matched (1-5) targets are shown. As a control, the temperate phages were shuffled ten times 9 
retaining the hexanucleotide content (Control). (b) Counts of spacers matching temperate phages from 10 
all genera with over 500 spacer-prophage matches. The total number of spacer-prophage matches is 11 
shown for each genus in brackets (i.e. n=X). Counts of matches are shown (0 or 1-5 mismatches, green 12 
and red). The number of temperate phages analysed is plotted (Prophage, purple) and the matches to 13 
shuffled prophages (Control, blue; not visible as only 0 to 10 counts). (c) Percentage of prophages 14 
within each genus that were targeted by self-priming spacers (1-5 mismatches). (d) Heatmap of the 15 
distribution of mismatches (0-5). Genera are as in (b) and data is shown as log(Count) for each genus, 16 
as the number of matches varied widely between genera.  17 
 18 
Extended Data Figure 8 | Self-targeting genomes are enriched for acr gene(s). The number of P. 19 
aeruginosa genomes with complete CRISPR-Cas systems that contain (+) or lack (-) genes encoding 20 
known Acr. For these strains, the total with perfect (0) or mismatched (1-5) self-targeting (ST) spacers 21 
to (a) anywhere in the genome or to (b) prophages are shown. For complete P. aeruginosa genomes 22 
all self-targeting events were analysed for matches to prophages using PHASTER37. The greater 23 
number of genomes with acr genes (Acr +) and self-targeting (ST +) compared to those without ST is 24 
significant (p = 8.14E-05, Fisher’s exact test, two sided, n=71).  25 
 26 
Extended Data Figure 9 | Presence of a superinfecting virulent phage does not alter 27 
immunopathological effects. (a) Bacterial and (b-c) phage titres upon (b) individual or (c) mixed 28 
infection of WT PA14 with phage DMS3 and virulent phage LMA2. (d-e) Resistance phenotypes 29 




CRISPR-Cas immune systems upon infection with phage DMS3 or with both phages DMS3 and LMA2, 1 
based on 24 random clones per replicate experiment. (g) Relative fitness of WT PA14 during 2 
competition with PA14 ∆cas7 in the presence or absence of phages DMS3 and LMA2. All panels (a-g) 3 
show means of 6 biological replicates and error bars indicate 95% c.i. (h-o) Simulations of population 4 
and evolutionary dynamics during infection of bacteria carrying CRISPR-Cas systems with a mixed 5 
population of unrelated virulent and temperate phages. Graphs show densities of (h,i) susceptible 6 
hosts, CRISPR-resistant bacteria, lysogens and (j,k) free viruses over time, as well as (l,m) the 7 
frequencies of temperate phages in a population composed of both temperate and virulent types. Note 8 
that temperate phage can transmit both horizontally and vertically, whereas virulent phage can transmit 9 
only horizontally and can superinfect the lysogens (because temperate and virulent phages are 10 
unrelated). (n,o) Frequencies of evolutionary loss of CRISPR-Cas system in the lysogen population 11 
over time. The simulations shown in (h, j, l, n) reflect the scenario where bacteria can evolve CRISPR-12 
based resistance against both phages, whereas (I, k, m, o) reflects the situation where CRISPR-based 13 
resistance does not evolve against the virulent phage and bacteria instead evolve costly surface-based 14 
resistance (as it is the case in the experiments). See also supplementary information for a detailed 15 
description of the simulations. 16 
 17 
Extended Data Table 1 | Genomic deletions and prophage insertion sites in DMS3 late lysogen 18 
clones. 19 
aSum does not reach 100% as a proportion of hybrid reads that mapped PA14 genome did not allow to 20 
define a potential prophage insertion site.  21 
bSample contaminated with a Bacteriophage Insensitive Mutant (BIM) clone; sequencing data not 22 
interpretable 23 
cOnly 2607 bp of DMS3 DNA (including c-repressor gene) are inserted in bacterial genome at position 24 
5,834,730 25 
dMixed population - reads matching the CRISPR locus are still detectable but coverage is very low 26 
 27 
 28 
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Extended Data Table 1 | Genomic deletions and prophage insertion sites in DMS3 late 1 
lysogen clones. 2 
Strain Sample  name 
Name on 
ED Fig. 4 
Deleted region Prophage insertion site(s) 











WT117 WT_1 2,831,115 2,938,245 107,131 replace deleted region 73 
WT221 WT_2 2,879,871 2,938,280 58,410 
replace deleted region 44.2 
3,555,252 42.3 
WT3213 WT_3 2,880,477 2,938,285 57,809 replace deleted region 84 
WT4313 WT_4 2,878,050 2,938,509 60,460 






 - 0 0 0 nd nd 
WT6615 WT_5 2,812,027 2,938,165 126,139 
replace deleted region 42.0 
3,325,229 49.6 
WT7AnneD1 WT_6 2,743,638 2,938,176 194,539 




WT8AnneD2 WT_7 2,818,271 2,938,290 120,020 
2,335,454 24.8 
2,652,167 29.6 




cas11114 ∆cas1_1 2,918,943 2,970,427 51,485 3,079,190 84.3 
cas1222 ∆cas1_2 2,706,504 2,938,538 232,035 




 - 0 0 0 partial nd 
cas14415 ∆cas1_3 2,879,882 2,938,523 58,642 
2,730,814 44.1 




 - 2,902,848 2,938,280 35,433 
replace deleted region 78.8 
2,934,176 7.7 
cas16611 ∆cas1_4 2,879,874 2,938,285 58,412 replace deleted region 94.2 
PA14 
∆cas7  
cas7114 ∆cas7_1 0 0 0 1,120,809 86.7 
cas72211 ∆cas7_2 0 0 0 410,059 82.9 
cas73313 ∆cas7_3 0 0 0 5,725,887 74.7 
cas7442 ∆cas7_4 0 0 0 5,743,045 84.5 
cas7554 - 0 0 0 905,180 37.9 
cas7669 - 0 0 0 1,667,097 75.0 
 3 
a
Sum does not reach 100% as a proportion of hybrid reads that mapped PA14 genome did not allow to define 4 
a potential prophage insertion site.  5 
b
Sample contaminated with a Bacteriophage Insensitive Mutant (BIM) clone; sequencing data not interpretable 6 
c
Only 2607bp of DMS3 DNA (including c-repressor gene) are inserted in bacterial genome at position 5,834,730 7 
d
Mixed population - reads matching the CRISPR locus are still detectable but coverage is very low 8 
 
Supplementary Methods: 
Epidemiological modelling of phage dynamics 
We develop an epidemiological model to understand the joint dynamics of both virulent and temperate 
phages in a bacterial host population with a functional CRISPR-Cas system. Initially, a fully 
susceptible bacterial population is inoculated with 10# virions. Like in our batch culture experiments, 
we model the sequential transfer of the community after transferring 1% of the population every day 
into a new environment with fresh medium. We contrast two different scenarios that differ only in the 
initial composition of the phage inoculum. 
 
Scenario 1: Competition between related phages with virulent and temperate life cycles 
Following the experiment carried out in our study (Fig. 2a,b) we assume that the phage inoculum is 
composed of two variants of a single phage species: a temperate strain (the density of this strain is 
noted $%(')), and a virulent strain (the density of this strain is noted $)(')). Both strains can infect 
susceptible bacteria (the density of susceptible bacteria is noted *(')). Upon infection, three different 
outcomes are possible:  
(i) Because the two viruses are related, they share the same genome (apart from the gene 
controlling lysis/lysogeny) and the bacteria can evolve CRISPR resistance against both 
virus types (the density of resistant bacteria is noted +(')) with a probability of acquisition 
,. 
(ii) The phage infection leads to the lysis of the infected cell and produces a burst of - new 
virions. The infection by the virulent phage always results in the lysis of the bacteria but 
the infection by the temperate phage only leads to lysis with a probability 1 − /. 
(iii) With probability /, the infection with the temperate phage results in the integration of the 
virus in the bacterial genome which yields a lysogenic bacterium (the density of lysogenic 
bacteria is noted 0(')). 
When lysogens reproduce, they transmit the temperate phage vertically. Note that superinfection 
inhibition prevents both the temperate and the virulent phages from re-infecting lysogenic bacteria 
(because both phages are assumed to be related). The prophage in the lysogenic bacterium can 
reactivate and lyse host cells. Imperfect targeting of the prophage by CRISPR immunity is assumed 
to yield large induction rates 123 of the prophage. Lysogenic bacteria can lose the CRISPR locus with 
a rate 4 (the density of lysogenic bacteria with an inactive CRISPR is noted 056(')). Prophages in 
these lysogenic bacteria are no longer targeted by CRISPR and have a lower induction rate 156 <
123. 
 
The above life cycle yields the following set of differential equations (see Supplementary Table 1 for 





*̇(') = :;1 − <(')=*(') − >?*(')$(') − @*(') 
+̇(') = >?,(1 − A)*(')$(') + :;1 − <(')=+(') − @+(') 
0̇(') = >?;1 − ,(1 − A)=/*(')$%(') + C(1 − 4);1 − <(')=0(')
− (123(1 − A) + 156A +@)0(') 
0̇56(') = C;1 − <(')=;40(') + 056(')= − (156 +@)056(') 
$̇%(') = >?;1 − ,(1 − A)=(1 − /)*(')$%(')- + (123(1 − A) + 156A)0(')-
+ 156056(')- − (><(') + @))$%(') 
$̇)(') = >?;1 − ,(1 − A)=*(')$)(')- − (><(') + @))$)(') 
 
(1) 
with: <(') = *(') + +(') + 0(') + 056(') and $(') = $%(') + $)('). 
 
Note that the parameter A refers to the ability for the phage to produce an anti-CRISPR protein (Acr) 
that prevents both the evolution of CRISPR resistance and immunity against the prophage in 
lysogenic cells. We plot the dynamics of bacteria and phages across transfers with a wildtype phage 
(Extended Data Fig. 6a-d) and an Acr-phage (Extended Data Fig. 6e-h). These dynamics are very 
consistent with the experimental results (compare with Fig. 2a,b). In particular, we recover the short-
term increase in the frequency of the virulent phage during the initial epidemic. In addition, we do 
recover the increase in frequency of bacteria with an inactive CRISPR when the phage does not 
encode an Acr, but not when the phage encodes an Acr. 
 
Scenario 2: Competition between unrelated phages with virulent and temperate life cycles 
In this second scenario we assume that the virulent and the temperate viruses are unrelated. This 
has two main consequences. First, CRISPR immunity can be specific to each strain (after the 
acquisition of a spacer targeting one strain or the other). We thus have to consider three different 
types of resistant bacteria (see Table S1 for the definition of the parameters of this model):  
(1) bacteria resistant to the temperate virus only (the density of these bacteria is noted +%('));  
(2) bacteria resistant to the virulent virus only (the density of these bacteria is noted +)('));  
(3) bacteria resistant to both temperate and virulent viruses after the acquisition to two spacers, one 
against each virus type (the density of these bacteria is noted +%)(')), 
Second, a lysogenic bacterium can be superinfected by the virulent phage. 
This yields a modified set of differential equations:   
*̇(') = :;1 − <(')=*(') − >?*(')$(') − @*(') 
+̇%(') = >?,(1 − A)*(')$%(') + :;1 − <(')=+%(') − (>?$)(') + @)+%(') 
+̇)(') = >?,(1 − A)*(')$)(') + :;1 − <(')=+)(') − (>?$%(') + @)+)(') 
+̇%)(') = >?,(1 − A);+)(')$%(') + +%(')$)(')= + :;1 − <(')=+%)(') − @+%)(') 
(2) 
0̇(') = >?;1 − ,(1 − A)=/*(')$%(') + C(1 − 4);1 − <(')=0(')
− (123(1 − A) + 156A +@)0(') − >?0(')$)(') 
0̇)(') = >?,(1 − A)0(')$)(') + C(1 − 4);1 − <(')=0)(')
+ >?;1 − ,(1 − A)=/+)(')$%(') − (123(1 − A) + 156A +@)0)(') 
0̇56(') = C;1 − <(')= D4;0(') + 0)(')= + 056(')E − >?056(')$)(')
− (156 +@)056(') 
$̇%(') = >?;1 − ,(1 − A)=(1 − /)(*(') + +))$%(')-
+ ;(123(1 − A) + 156A)0(') + 156056(')=- − (><(') + @))$%(') 
$̇)(') = >? D;1 − ,(1 − A)=;*(') + +% + 0(')= + 056(')E $)(')- − (><(')
+ @))$)(') 
 
with: <(') = *(') + +%(') + +)(') + +%)(')FGGGGGGHGGGGGGI
3J(K)
+ 0(') + 0)(') + 056(')FGGGGGGHGGGGGGI
LJ(K)
. 
This scenario yields more complex dynamics because it can maintain transient polymorphism in both 
bacteria and phage populations through negative frequency dependence (Extended Data Fig. 9h, j, l, 
n). The presence of a virulent phage in the population maintains the fitness benefit associated with 
carrying an active CRISPR-Cas system (note how the selection for CRISPR is associated with the 
high frequency of the virulent phage). Yet, after the spread of resistant bacteria, the virulent phage is 
outcompeted by the temperate phage and, among the lysogens, there is selection for the loss of the 
CRISPR-Cas system. 
 
To match the biology of our experimental system we also modeled a situation where CRISPR-Cas 
cannot acquire immunity against the virulent phage. Yet, we allow the evolution of costly surface 
mutations that block the infection by the virulent phage. This yields the following set of differential 
equations (where the subscript $ refers to surface mutation blocking the virulent phage):    
  
*̇(') = :(1 − 43);1 − <(')=*(') − >?*(')$(') − @*(') 
+̇%(') = >?,(1 − A)*(')$%(') + :(1 − 43);1 − <(')=+%(') − (>?$)(') + @)+%(') 
+̇)(') = :43;1 − <(')=*(') + :(1 − M);1 − <(')=+)(') − (>?$%(') + @)+)(') 
+̇%)(') = >?,(1 − A)+)(')$%(') + :43;1 − <(')=+%(')
+ :(1 − M);1 − <(')=+%)(') − @+%)(') 
0̇(') = >?;1 − ,(1 − A)=/*(')$%(') + C(1 − 4)(1 − 43);1 − <(')=0(')
− (123(1 − A) + 156A +@)0(') − >?0(')$)(') 
0̇)(') = C(1 − 4)43;1 − <(')=0(') + C(1 − 4)(1 − M);1 − <(')=0)(')
+ >?;1 − ,(1 − A)=/+)(')$%(') − (123(1 − A) + 156A +@)0)(') 
(3) 
0̇56(') = C(1 − 43);1 − <(')=;40(') + 056(')= − >?056(')$)(')
− (156 +@)056(') 
0̇56,)(') = C;1 − <(')= D43056(') + 4(1 − M)0)(') + (1 − M)056,)(')E
− (156 +@)056,)(') 
$̇%(') = >?;1 − ,(1 − A)=(1 − /)(*(') + +))$%(')-
+ O(123(1 − A) + 156A);0(') + 0)(')=
+ 156 D056(') + 056,)(')EP- − (><(') + @))$%(') 




We observe very similar dynamics as in the previous scenario: the spread of multi-resistant hosts, the 
fixation of the temperate phage and the loss of CRISPR. However, when the cost of resistance against 
the virulent phage is high, the virulent phage can be maintained in the population because a 
polymorphism is maintained between susceptible and resistant bacteria by negative frequency 
dependent selection (Extended Data Fig. 9i, k, m, o). Note however, that the presence of the virulent 
phage does not maintain CRISPR because in this scenario, bacteria do not rely on CRISPR immunity 
to resist infection by the virulent phage.   
 
Overall conclusion of modelling: Our model tracks both the evolution of phages (life cycle, evolution 
of acr) and bacteria (evolution of CRISPR immunity or surface mutations). The good fit between the 
output of the model (Extended Data Fig. 6 and 9h-o) and our experimental results (Fig. 2 and 
Extended Data Fig. 9a-g, respectively) supports the hypothesis that the cost of virulence is driving 
the evolution of phage life cycle (lytic versus lysogenic life cycle) and the cost of auto-immunity in 
lysogenic bacteria is driving the evolutionary loss of CRISPR-Cas in bacteria. Besides, the model 
allows to explore other scenarios such as the competition between unrelated viruses. Most scenarios 
lead to the evolutionary loss of CRISPR-Cas in lysogens. Indeed, in our model, once resistance 
against virulent phage is present (i.e. CRISPR-based or surface mutant), there is no need to invest in 
immunity because it carries high fitness costs in lysogenic bacteria.  
Note that our experiments (and our model) describe the evolution of a closed system. More complex 
scenarios, for example where a bacterial population is constantly exposed to new unrelated virulent 










Supplementary Table 1: Parameters of the model with default values 
 
Parameter Definition Default value 
: Growth rate of uninfected cells 0.7	ℎUV 
C Growth rate of infected cells 0.7	ℎUV 
W Carrying capacity 10X	MYZZ[ 
- Burst size 50	]^:^_`. MYZZUV 
> Adsorption constant 5	 × 10UVb	ℎUV. MYZZUV 
? Probability of fusion after adsorption 10UV 
/ Probability of genome integration 0.5 
, Probability of acquisition of a new spacer targeting 
the phage 
10U# 
A Efficacy of CRISPR inhibition by Acr 0 (wildtype phage) 
1 (Acr-phage) 
123  Induction rate of the prophage when the CRISPR 
immunity targets the prophage 
5	10Uc		ℎUV 
156 Induction rate of the prophage when the CRISPR 
immunity does not target the prophage 
10Ud	ℎUV 
@ Mortality rate of bacteria 0	ℎUV 
@)  Mortality rate of virions 0	ℎUV 
4 Mutation towards CRISPR KO 10U# 
43  Mutation towards sm resistance against the lytic virus (see equation (3)) 
10U# 
M Fitness cost associated with sm resistance against 
the lytic virus (see equation (3)) 
0.5 
  
Bioinformatic analysis of widespread priming off temperate phages  
The maladaption hypothesis predicts that bacteria that continue to benefit from prophages, yet contain 
mismatched spacers against the prophage, would be under pressure to reduce or lose CRISPR-Cas 
function. Specifically, bacteria with spacers having near matches within the prophage would be 
maladapted (e.g. PA14 CRISPR2 spacer 1/DMS3) as self-targeting or self-priming could occur. If this 
were widespread, we predict that (i) spacers matching prophages would be common within the pan-
spacer repertoire for a genus (ii) genomes with self-targeting or self-priming spacers would either 
have acr(s), or that the CRISPR-Cas system would be non-functional.  
(i) Spacers matching temperate phages are common 
To test if it is common for bacteria to possess pre-existing spacers that may promote priming off 
temperate phages, we tested a set of all spacers from 171,361 bacterial genomes against a database 
of prophage sequences21. Genomes from RefSeq 93 (n=136,507) were supplemented with Genbank 
genomes absent from RefSeq (giving a total of 171,361). CRISPR arrays were identified using 
CRISPRDetect34; 1,239,937 spacers were collected (spacers of atypical size were removed as 
potential artefacts) and identified by the genomic contig, position and species. A set of prophage 
sequences from the PHAST21 database  were de-replicated and split into 133 genera from 6570 
complete genomes (total n=19,996). For each bacterial genus in which prophages were found, we 
searched for prophage targets using a non-redundant set of spacers (generated by CD-HIT-dup, 
default parameters) from species within the same genus (using BLASTN; blastn-short, e-value cut-
off=0.001, DB-size=10000, word-size=7, gap-open penalty=10, gap-extension=-2, mismatch=-1, 
match reward=1). A total of 85,931 hits with 0-5 mismatches were identified within all genera (e.g. 
from any Streptococcus spacer against any Streptococcus prophage there were 10,850 hits).  
Compared with a negative control, where the non-redundant prophage database was hexanucleotide 
shuffled 10 times to reveal the number of random hits (276 +/- 30), there was a significant increase 
in within-genus prophage hits from spacers with either 0 mismatches or 1-5 mismatches (Extended 
Data Fig. 7a). Next, the distributions of mismatch frequencies were computed per genus for those 
with over 500 within genus spacer-phage matches (0-5 mismatches). All genera had significantly 
more matches compared with a shuffled dataset (Extended Data Fig. 7b). The distributions of number 
of mismatches differed between genera. For example, Pseudomonas spp. and Mycobacterium spp. 
had many exact matches but other genera displayed more evenly distributed mismatch frequencies 
(Extended Data Fig. 7c). In conclusion, it is common for many bacterial genera to contain pre-existing 
spacers that are likely to either provide interference or priming off invading temperate phage 
genomes. These data support maladaptation hypothesis of CRISPR-Cas against temperate phages.  
(ii) Self-targeted and self-primed genomes are enriched for Acr(s). 
Our experimental data indicated that the maladaptive effects of CRISPR-Cas against temperate 
phages can be countered through Acr proteins or be tolerated due to CRISPR-Cas inactivation or 
loss. First, we sought to further test this finding by searching sequenced bacterial genomes for self-
targeting or self-priming and whether this correlated with the presence of acr genes. Strains of P. 
aeruginosa provide a good test set since there are many sequenced isolates, several acr genes have 
been identified, and prophages are common. In addition, the main CRISPR-Cas types are I-E and I-
F, where priming has been demonstrated experimentally.  
To test if self-targeting leads to increased Acr presence, CRISPR arrays were identified using 
CRISPRDetect in 98 of 168 P. aeruginosa genomes. CRISPRCasFinder35 was used to assign 
whether cas gene sets were complete and only those strains analysed further. These strains were 
characterized as either containing no self-targets or self-matches using the self-targeting spacer 
searcher (STSS)36, with the BLASTN parameters modified to permit up to 5 mismatches (0-5). Next, 
acr genes were identified by building hmm using proteins with >40% identity to the set of known acr 
genes from STSS. We observed a statistically significant enrichment for increased frequencies of acr 
genes in the presence of self-targeting spacers, in support of our experimental data (Extended Data 
Fig. 8a). An even stronger association between acr genes and self-matches was observed when the 
analysis considered self-targets within prophages (identified using PHASTER37) (Extended Data Fig. 
8b). 
Note that further analysis of this dataset did not reveal increased frequencies of cas gene deletions 
from genomes with priming spacers against prophages (data not shown). This is likely explained by 
(i) the limited number of P. aeruginosa genomes that that match our search criteria, (ii) genetic linkage 
that causes deletions to typically encompass both cas genes and CRISPR arrays (Extended Data 
Fig. 4c-e), and (iii) presence of unidentified acr genes in prophage genomes that are not detected by 
our search algorithm due to sequence divergence from currently described acr genes.  
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Supplementary Figure 1 : Source data images for PCR amplification results presented in Figure 4a-d. 
Cropped areas are indicated by white boxes. 
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